WILMINGTON, DE / ACCESSWIRE / March 28, 2023 / Transparency Market Research Inc. - The pulmonary valve replacement market was valued at USD 1.0 Bn in 2022 and is projected to surpass USD 1.6 Bn by ...

Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced it received FDA approval for its transcatheter valve with adaptive prestent for ...

The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...

Vancouver, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The worldwide market for transcatheter pulmonary valve replacement reached a value of USD 44.62 Million in 2022. As per the most recent assessment ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio At 10 years, transcatheter pulmonary ...

University of MIchigan Health C.S. Mott Children's Hospital, part of Ann Arbor-based Michigan Medicine, is among the first in the U.S. to perform a catheter-based pulmonary valve replacement on a ...

Edwards Lifesciences announced the approval Monday for management of both pediatric and adult patients with severe pulmonary regurgitation on echocardiography who are candidates for surgical ...

Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...

Device preparation for downsizing the diameter of the pulmonary trunk. We designed and developed a self-expandable stent constructed from a single 0.22-mm nitinol wire in the shape of a conduit with a ...

Pulmonary Heart Valve Replacement market players – Edwards Lifesciences Corporation, Boston Scientific Corporation, Medtronic Inc. among others represent the global Pulmonary Heart Valve Replacement ...